Planta Med 2016; 82(S 01): S1-S381
DOI: 10.1055/s-0036-1596449
Abstracts
Georg Thieme Verlag KG Stuttgart · New York

Arginase inhibitory properties of stilbenes from Cyperaceae species

K Arraki
1   FDE EA4267, University of Bourgogne Franche-Comté, F-25000 Besançon, France
,
A Descendit
2   GESVAB EA4577, ISVV, University of Bordeaux, 33882 Villenave d'Ornon, France
,
A Zedet
1   FDE EA4267, University of Bourgogne Franche-Comté, F-25000 Besançon, France
,
C Demougeot
1   FDE EA4267, University of Bourgogne Franche-Comté, F-25000 Besançon, France
,
C Girard-Thernier
1   FDE EA4267, University of Bourgogne Franche-Comté, F-25000 Besançon, France
› Author Affiliations
Further Information

Publication History

Publication Date:
14 December 2016 (online)

 

Stilbenoids constitute a group of natural phenolic compounds, whose distribution within the plant kingdom is limited to species that have acquired ability to synthesize this kind of molecules during the evolution [1]. These compounds have received much attention because of their anticancer, antioxidant, anti-inflammatory and cardioprotective activities [2]. Recently the stilbene piceatannol-3'-O-β-D-glucopyranoside was described as an active component of rhubarb with rat arginase inhibitory activity [3]. We also showed that resveratrol and piceatannol possessed in vitro inhibitory activity against liver bovine arginase. The interest for arginase as a therapeutic target has grown in the last years when the excessive arginase activity in mammals was shown to be associated with an endothelial dysfunction leading to various diseases including hypertension. Then the use of arginase inhibitors has been proved to be beneficial in various diseases including cardiovascular diseases [4]. Therefore, continuing our systematic research of new arginase inhibitors from natural sources, we first looked into plants from Cyperaceae family, which is known to be a source of oligostilbenoids derived from piceatannol and resveratrol. Phytochemical studies on Cyperus and Carex species were performed using analytical and preparative HPLC leading to twelve compounds, including monomers, dimers, trimers and tetramers of resveratrol. LC-MS and NMR spectroscopy were used for identification of the compounds. We studied the potential of these stilbenes as inhibitors of mammal arginase (liver bovine arginase). Four compounds (cyperusphenols A and B, scirupsin and vitisin B) showed significant inhibition of arginase, with percentages inhibition ranging from 85 to 95% at 100µM, and confirming that stilbenes would be very useful for the development of new pharmaceutical products.

Keywords: Arginase inhibitors, stilbenes, cardiovascular diseases, Cyperaceae, Cyperus, Carex.

References:

[1] Rivière C, Pawlus AD, Mérillon JM. Natural stilbenoids: distribution in the plant kingdom and chemotaxonomic interest in Vitaceae. Nat Prod Rep 2012; 29: 1317 – 1333

[2] Flamini R, Mattivi F, De Rosso M, Arapitsas P, Bavaresco L. Advanced knowledge of three important classes of grape phenolics: Anthocyanins, stilbenes and flavonols. Int J Mol Sci 2013; 14: 19651 – 19669

[3] Woo A, Min B, Ryoo S. Piceatannol-3-O-β-D-glucopyranoside as an active component of rhubarb activates endothelial nitric oxide synthase through inhibition of arginase activity. Exp Mol Med 2010; 42: 524 – 532

[4] Caldwell RB, Toque HA, Narayanan SP, Caldwell RW. Arginase: an old enzyme with new tricks. Trends Pharmacol Sci 2015; 36: 395 – 405